20 research outputs found
Hippocampal neuronal cells that accumulate α-synuclein fragments are more vulnerable to Aβ oligomer toxicity via mGluR5--implications for dementia with Lewy bodies.
BackgroundIn dementia with Lewy bodies (DLB) abnormal interactions between α-synuclein (α-syn) and beta amyloid (Aβ) result in selective degeneration of neurons in the neocortex, limbic system and striatum. However, factors rendering these neurons selectively vulnerable have not been fully investigated. The metabotropic glutamate receptor 5 (mGluR5) has been shown to be up regulated in DLB and might play a role as a mediator of the neurotoxic effects of Aβ and α-syn in vulnerable neuronal populations. In this context, the main objective of the present study was to investigate the role of mGluR5 as a mediator of the neurotoxic effects of α-syn and Aβ in the hippocampus.ResultsWe generated double transgenic mice over-expressing amyloid precursor protein (APP) and α-syn under the mThy1 cassette and investigated the relationship between α-syn cleavage, Aβ, mGluR5 and neurodegeneration in the hippocampus. We found that compared to the single tg mice, the α-syn/APP tg mice displayed greater accumulation of α-syn and mGluR5 in the CA3 region of the hippocampus compared to the CA1 and other regions. This was accompanied by loss of CA3 (but not CA1) neurons in the single and α-syn/APP tg mice and greater loss of MAP 2 and synaptophysin in the CA3 in the α-syn/APP tg. mGluR5 gene transfer using a lentiviral vector into the hippocampus CA1 region resulted in greater α-syn accumulation and neurodegeneration in the single and α-syn/APP tg mice. In contrast, silencing mGluR5 with a lenti-shRNA protected neurons in the CA3 region of tg mice. In vitro, greater toxicity was observed in primary hippocampal neuronal cultures treated with Aβ oligomers and over-expressing α-syn; this effect was attenuated by down-regulating mGluR5 with an shRNA lentiviral vector. In α-syn-expressing neuronal cells lines, Aβ oligomers promoted increased intracellular calcium levels, calpain activation and α-syn cleavage resulting in caspase-3-dependent cell death. Treatment with pharmacological mGluR5 inhibitors such as 2-Methyl-6-(phenylethynyl)pyridine (MPEP) and 3-((2-Methyl-4-thiazolyl)ethynyl)pyridine (MTEP) attenuated the toxic effects of Aβ in α-syn-expressing neuronal cells.ConclusionsTogether, these results support the possibility that vulnerability of hippocampal neurons to α-syn and Aβ might be mediated via mGluR5. Moreover, therapeutical interventions targeting mGluR5 might have a role in DLB
Drugst.One -- A plug-and-play solution for online systems medicine and network-based drug repurposing
In recent decades, the development of new drugs has become increasingly
expensive and inefficient, and the molecular mechanisms of most pharmaceuticals
remain poorly understood. In response, computational systems and network
medicine tools have emerged to identify potential drug repurposing candidates.
However, these tools often require complex installation and lack intuitive
visual network mining capabilities. To tackle these challenges, we introduce
Drugst.One, a platform that assists specialized computational medicine tools in
becoming user-friendly, web-based utilities for drug repurposing. With just
three lines of code, Drugst.One turns any systems biology software into an
interactive web tool for modeling and analyzing complex protein-drug-disease
networks. Demonstrating its broad adaptability, Drugst.One has been
successfully integrated with 21 computational systems medicine tools. Available
at https://drugst.one, Drugst.One has significant potential for streamlining
the drug discovery process, allowing researchers to focus on essential aspects
of pharmaceutical treatment research.Comment: 45 pages, 6 figures, 7 table
Mechanisms of Hybrid Oligomer Formation in the Pathogenesis of Combined Alzheimer's and Parkinson's Diseases
Background: Misfolding and pathological aggregation of neuronal proteins has been proposed to play a critical role in the pathogenesis of neurodegenerative disorders. Alzheimer’s disease (AD) and Parkinson’s disease (PD) are frequent neurodegenerative diseases of the aging population. While progressive accumulation of amyloid b protein (Ab) oligomers has been identified as one of the central toxic events in AD, accumulation of a-synuclein (a-syn) resulting in the formation of oligomers and protofibrils has been linked to PD and Lewy body Disease (LBD). We have recently shown that Ab promotes a-syn aggregation and toxic conversion in vivo, suggesting that abnormal interactions between misfolded proteins might contribute to disease pathogenesis. However the molecular characteristics and consequences of these interactions are not completely clear. Methodology/Principal Findings: In order to understand the molecular mechanisms involved in potential Ab/a-syn interactions, immunoblot, molecular modeling, and in vitro studies with a-syn and Ab were performed. We showed in vivo in the brains of patients with AD/PD and in transgenic mice, Ab and a-synuclein co-immunoprecipitate and form complexes. Molecular modeling and simulations showed that Ab binds a-syn monomers, homodimers, and trimers, forming hybrid ringlike pentamers. Interactions occurred between the N-terminus of Ab and the N-terminus and C-terminus of a-syn. Interacting a-syn and Ab dimers that dock on the membrane incorporated additional a-syn molecules, leading to th
Rapid, concurrent alterations in pre- and postsynaptic structure induced by naturally-secreted amyloid-β protein
Job file for the creation/design of stained glass from either the Charles J. Connick Studio (1912-1945) or the Charles J. Connick Associates studio (1945-1986). The job file contains a job number, location information, date of completion, size, contact information, price, and a description of the project. This particular job file contains information on a job located at: Valley City, North Dakota. Our Saviour's Lutheran Church
Sample description by socio-demographic variables.
Sample description by socio-demographic variables.</p
Mean of medical service consumption among the elderly population in the pre-COVID-19 period (P1), and during COVID-19 lockdown (P2) by socio-demographic variables.
Mean of medical service consumption among the elderly population in the pre-COVID-19 period (P1), and during COVID-19 lockdown (P2) by socio-demographic variables.</p
Mean of service consumption for the elderly population.
According to study periods–pre COVID-19 (P1) and during COVID-19 lockdown (P2).</p
Logistic regression results for the prediction of service consumption during COVID-19 lockdown by socio-demographic variables and pre-COVID-19 service consumption.
Logistic regression results for the prediction of service consumption during COVID-19 lockdown by socio-demographic variables and pre-COVID-19 service consumption.</p
Mean service refusal (ambulance and doctor visit) among the elderly population in the pre-COVID-19 period (P1) and during COVID-19 lockdown (P2) by socio-demographic variables.
Mean service refusal (ambulance and doctor visit) among the elderly population in the pre-COVID-19 period (P1) and during COVID-19 lockdown (P2) by socio-demographic variables.</p